Weight Loss Capsule Not a 'Game Changer'

Monday, 23 Jun 2014 12:32 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

A capsule that's designed to help people lose weight by temporarily expanding in their stomach in order to make them feel full just before meals is not the breakthrough some anticipated, a new study suggests.

After 12 weeks, people who took the capsule -- called Gelesis100 -- lost 6.1 percent of their weight, compared with 4.1 percent for people who were given a placebo.

That difference is "very modest" Dr. Daniel Bessesen, an endocrinologist at the University of Colorado, told The New York Times. He was not involved in the study.

"It doesn't look like a game changer," Bessesen added.

However, the findings presented Sunday at an endocrinology meeting in Chicago were hailed by Boston-based Gelesis, which developed the capsule. The company said it will launch a larger study next year in effort to win regulatory approval for the capsule.

"I'm definitely impressed, absolutely," study lead investigator Dr. Arne Astrup, head of the department of nutrition, exercise and sports at the University of Copenhagen in Denmark, told The Times.

Gelesis100 is safer than many existing weight loss drugs, which act chemically on the brain to influence appetite, Astrup said.
 

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Plant-Based Vaccines Challenge Big Pharma Dominance

Wednesday, 01 Oct 2014 08:07 AM

Two tiny companies are preparing to challenge some of the world's largest drugmakers in the battle for dominance in the  . . .

Irritable Bowel Drug Shows Promise in Trial

Wednesday, 01 Oct 2014 07:57 AM

Ardelyx Inc. said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of . . .

Ebola in the US: What You Need to Know

Wednesday, 01 Oct 2014 07:50 AM

U.S. health officials have warned for months that someone infected with Ebola could unknowingly carry the virus to this  . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved